That is necessary, since the way a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and work. To put it simply, we need to know how these proteins fold if we want a drug to work. Historically, this has been an experimental process (jeff brown 1 biotech company). However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much easier to develop drugs that do what they're designed to do. This was an advancement practically nobody observed. However it's going to have profound ramifications for treating illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this area, too. Shifting topics It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (the legacy report prediction). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it pulled back maybe substantially before going higher - jeff brown prediction for 2021. I have actually been covering bitcoin for a long period of time now. One of the first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I entitled my report "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time. We were primarily informing readers. But that's not the big concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
Which's a big reason I'm bullish on it this year. self-driving cars. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are numerous excellent private companies on the brink of striking the public markets And I've been dealing with a brand-new way for you to invest even prior to these business go public.
This chance has been constructing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to book your spot free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers understand that tech isn't our typical beat (democratic republic). And when it pertains to tech investing, we leave it to the professionals. Thankfully, we have numerous such specialists in our Rolodex. Our associate Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing professionals we know (diplomatic relations). In truth, he had a number of triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and forecast what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential growth and producing extraordinary opportunities for investors. I want to make sure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see being available in the next 12 months Our new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. exponential tech investor. However in spite of what lots of readers might believe, this is a trend that's simply starting. Although the COVID-19 pandemic disrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (jeff brown 1 biotech). Losing 2 months of manufacturing and sales actually affects the number of 5G gadgets are sold in the fiscal year. When you consider all of that, selling 250 million units is exceptional. More significantly, the hold-ups brought on by the pandemic created a lot of suppressed need. And that demand is now going to be pressed into 2021. In reality, I anticipate that more than 500 million 5G devices will be shipped in 2021 - jeff brown predictions for 2021. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its three different phases.
In Stage Two, 5G devices go on sale. 5G phones and other products begin to reach customers. And in Stage 3, 5G services begin to be used (jeff brown tech stock 2021). That's when we begin to see applications operating on 5G networks. Consider things like massive multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will start Stage Three by this summer season. This begins something of a virtuous cycle: The majority of people do not truly care about the technology. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In fact, 5G is going to open a suite of incredible applications: self-driving cars and trucks, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The financial investment opportunities moving forward will be massive. Stepping away from 5G, the next crucial innovation I anticipate in 2021 is CRISPR genetic modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most amazing developments in biotechnology. At a high level, CRISPR is a technology that can modify our hereditary makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable concept however with our hereditary code. "Typos" in our genome can lead to disease. CRISPR can remedy these "typos." For many years, CRISPR was primarily a niche technology that wasn't well comprehended. And during that time, there were really only three companies running in this area. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're treating diseases and seeing that this technology just works. And as a result, a "2nd crop" of early-stage CRISPR business is going public and providing extraordinary returns. This whole market is effectively a greenfield opportunity.
There's space for lots of business to exist in this space. second wave. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more genetic editing business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can properly predict the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That is very important due to the fact that the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been an experimental process. However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one however several drug therapies produced utilizing this innovation. This was one of those breakthroughs that almost no one saw. But it's going to have extensive ramifications for treating illness. And, of course, there will be plenty of investment chances in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back perhaps considerably prior to going greater. I have actually been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin - jeff brown genetic sequencer stock. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. However at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time.
However no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. what is the legacy report predicting. Mass, Mutual is a 150-year-old institution. So believe about that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and claims the information is up to date as of February 2021, but we could not independently validate this claim. Offered Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this moment. Brown is best understood for his sage-like ability to choose winning technology stocks. He invested more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent perspective on the market. He's constantly on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Near Future Report.
That's high praise, however it's not ridiculously reasoned. Brown has an exceptional credibility as a stock-picker, and he successfully anticipated some of the most significant financial occasions of the past 20 years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it best each time, but Jeff Brown's accurate forecasts have actually made him legions of dedicated fans. That states a lot about his ability. The Future Report is published by Brownstone Research study, a prominent financial research publisher. Brownstone Research provides a number of research study services with a wide variety of expertises - jeff brown 1 biotech.
The company is also associated with Bonner & Partners, another well-respected research study publisher - bleeding edge. On its website, Brownstone says its objective is to supply retail investors with professional-grade research: "For too long, the best investment research study has actually not been readily available to specific financiers. It has actually been typically reserved for financial investment banks, hedge funds, private equity, and high-net-worth clients. jeff bezos. The mission of Brownstone Research is to make that kind of proprietary research offered to any investors wanting to acquire an edge in the markets. The goal is basic to deliver distinct and rewarding financial investment research found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he likewise acts as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research study is a powerhouse publisher with lots to provide its customers. After years of constant success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout many of America. If you know even a little bit about the market, you understand that he has a reputation as a King Midas of sorts. jeff brown predictions 2021. Whatever he touches turns to gold! Jeff is well conscious of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In fact, Brown thinks S.A.V. biotech stock. might be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge innovations: expert system and electrical vehicles. Musk hopes the combination will help him develop the first fully-autonomous, self-driving cars ever. It's absolutely nothing short of the vehicle market's Holy Grail. As you know, electric vehicles and self-driving car stocks have actually been big this year, however the Wall Street device has actually approved buzz without much concrete outcome. In spite of an extreme boost in competition over the previous few years, Brown still believes Musk has the very best chance of putting it all together.
tech might be the magic string that connects all of it together. S.A.V. stands for Shared Autonomous Lorry, and it might be the future of transport. Basically, this innovation would permit you to lease your automobile as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the vehicle and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a substantial piece of the profits. It sounds insane, however it could be closed than you believe.